02427 GUANZE MEDICAL
Closed Add to Porfolio| Key Financial Ratio (Fiscal Year: 12/2024) | |||
| Current | 5.64X | Oper Margin | 17.4% |
|---|---|---|---|
| LT Debt/Equity | 0.1% | Net Margin | 11.1% |
| Total Debt/Equity | 7.0% | Return on Equity | 6.6% |
| Price/Book | 1.24X | Return on Assets | 5.7% |
| (HKD 0.360) | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
| Net Profit (MHKD) | 18.30 | 30.38 | 20.12 | 28.05 | 34.47 |
|---|---|---|---|---|---|
| Net Profit Growth (%) | -39.8 | +51.0 | -28.3 | -18.6 | +38.1 |
| Earnings Per Share (HKD) | 0.02 | 0.032 | 0.026 | 0.037 | N/A |
| Earnings Per Share Growth (%) | -39.1 | +21.7 | -28.9 | +100.0 | N/A |
| Dividend Per Share (HKD) | No dividend | 0.021 | 0.021 | No dividend | No dividend |
| P/E* (X) | 18.46 | 11.25 | 13.69 | 9.73 | N/A |
| Yield (%) | N/A | 5.83 | 5.83 | N/A | N/A |
| Dividend Share (%) | N/A | 65.63 | 79.85 | N/A | N/A |
| Book NAV (HKD) | 0.290 | 0.313 | 0.307 | N/A | N/A |
| Auditors' Opinion | Unqualified | Unqualified | Unqualified | N/A | N/A |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2025-07-22 21:40:20
Latest Result
| (RMBMn) | 2024-12 | 2023-12 | Chg* (%) | 2022-12 |
| Cover Period (mths) | 12 | 12 | NA | 12 |
|---|---|---|---|---|
| Turnover | 155.74 | 156.072 | -0.2 | 177.112 |
| Operating Result | 26.309 | 38.65 | -31.9 | 29.962 |
| Profit Before Taxation | 26.309 | 38.65 | -31.9 | 29.962 |
| Taxation | 8.859 | 10.728 | -17.4 | 11.676 |
| Profit /( Loss) After Taxation | 17.45 | 27.922 | -37.5 | 18.286 |
| Minority Interests | 0.246 | 0.355 | -30.7 | 0.342 |
| Net Profit | 17.204 | 27.567 | -37.6 | 17.944 |
| Earnings Per Share () | 0.0195 | 0.0320 | -39.1 | 0.0263 |
| Dividend Per Share () | 0.0000 | 0.0210 | -100.0 | 0.0210 |
| Announcement Date | 2025-03-28 | 2024-03-28 | NA | 2023-03-28 |
* Annualised
Last Update Time: 2025-07-22 21:40:25
